Aristolochia longa Linn.
1. Taxonomic, Nomenclature & Therapeutic Summary Table
| Botanical Attribute | Pharmacognostic & Therapeutic Specification |
|---|---|
| Family | Aristolochiaceae. |
| English | European Birthwort. |
| Unani | Zaraawand Taweel. |
| Action | Oxytocic, abortifacient, emmenagogue. |
| Taxonomic Cohort | Genus Aristolochia (3 documented species); Family Aristolochiaceae (4 documented species). |
2. Classical Nomenclature, Taxonomy & Biogeographical Context
Aristolochia longa (taxonomically cited with authority Linn.) is an established medicinal plant species in Indian materia medica. It is classified under the botanical family Aristolochiaceae (primary family classification: Aristolochiaceae), placing it within a well-defined chemotaxonomic group of medicinal flora. Within botanical taxonomy, this taxon is cataloged directly under its primary accepted binomial without secondary botanical synonyms. Its biogeographical provenance spans the natural distribution range of its allied congeneric taxa.
Across classical and vernacular Indian systems of medicine, Aristolochia longa is recognized under distinct polyglot nomenclature: in English botanical and trade usage as European Birthwort; in the Unani-Tibb materia medica (recorded in The National Formulary of Unani Medicine and CCRUM literature) as Zaraawand Taweel. Romanized Sanskrit and Ayurvedic spellings follow standard National Academy of Ayurveda (Rashtriya Ayurveda Vidyapeeth) transliteration conventions, using double vowels to preserve authentic classical pronunciation across regional medical traditions.
3. Therapeutic Actions, Phytochemistry & Pharmacological Profile
In therapeutic and clinical pharmacognosy, the primary recorded actions and clinical indications of Aristolochia longa are: Oxytocic, abortifacient, emmenagogue. These traditional and clinical attributes reflect the plant part-specific pharmacological profile documented across classical Indian treatises and modern herbal pharmacopoeias.
Experimental phytochemistry, active chemical constituents, and pharmacological screening studies reported for Aristolochia longa establish the following evidence base: Aristolochic acid and its Me ester—strongly abortifacient, showed damage to liver and kidney. Roots— anti-oestrogenic. A cytotoxic lignan, savinin, has been isolated from the roots. Aristolochic acid also has an effect against adenosarcoma and HeLa cells in culture; however, it is suspected to be carcinogenic. Aristolochia extracts show a pronounced enhancement of phagocytosis by leucocytes, granulocytes and peritoneal macrophages, due to the presence of aristolochic acids. Tardolyt-coated tablets, which contain 0.3 mg of aristolochic acid, increase phagocytosis in healthy men. Aristolochic acid also exhibits reduction of some of the toxic effects of prednisolone, chloramphenicol and tetracycline in experiments in vitro, and a reduction in the rate of recurrent herpes lesions in vivo.

Botanical Reference 1: Aristolochia longa — Botanical specimen

Botanical Reference 2: Aristolochia longa — Botanical specimen

Botanical Reference 3: Aristolochia longa — Wikimedia Commons reference
4. Comparative Genus & Family Pharmacognosy
Taxonomically, the genus Aristolochia comprises 3 distinct medicinal species in Indian herbal literature. Closely allied congeneric species include: Aristolochia bracteolata (Action: Oxytocic, abortifacient, emmenagogue); Aristolochia indica (Action: Oxytocic, abortifacient, emmenagogue). Comparing Aristolochia longa alongside its congeners in genus Aristolochia highlights both shared secondary metabolite classes and species-specific organotropism across different ecological zones.
At the family level, Aristolochiaceae encompasses 4 documented medicinal species (0.22% of the 1,814-species flora). Other representative medicinal members of Aristolochiaceae include: Aristolochia bracteolata (Kitamaari), Aristolochia indica (Ishvari), Asarum europaeum (Asarbacca). In comparative pharmacognosy, evaluating species within the same botanical family aids quality control, authentication of crude drugs, and identification of chemotaxonomic markers.

Figure 1: Quantitative documentation profile across all 4 medicinal species of family Aristolochiaceae.
5. Pharmacopoeial Standards, Posology & Reference Framework
In clinical and traditional dispensing, preparation and administration of Aristolochia longa follow the plant-part modalities specified under its therapeutic action (Oxytocic, abortifacient, emmenagogue), guided by the standard posological principles of The Ayurvedic Pharmacopoeia of India (Vols. I–IV) and CCRAS formularies. Classical and modern pharmacognostic synchronization for Aristolochia longa integrates standards from The Ayurvedic Pharmacopoeia of India, The National Formulary of Unani Medicine, Formulary of Siddha Medicine, The Wealth of India (CSIR), Compendium of Indian Medicinal Plants (CDRI), Dictionary of Indian Medicinal Plants (CIMAP), German Commission E, ESCOP, WHO monographs, British Herbal Pharmacopoeia, and Natural Medicines Comprehensive Database.